Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launches of the Sterling® SL PTA Balloon Dilatation Catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below the knee. The Company plans to launch the product immediately in both markets.
The Sterling SL Balloon Catheter was developed specifically to address physicians' needs in treating below-the-knee arteries by providing a low tip profile, excellent deliverability and rapid deflation time. It expands the Company's leading line of low-profile peripheral angioplasty balloon catheters, which includes the Sterling and Sterling ES products.
"The introduction of the Sterling SL Balloon Catheter will provide the length options I need to address below-the-knee procedures for patients with peripheral artery disease," said Kenneth Kollmeyer, M.D., F.A.C.S., DFW Vascular Group and Chief of Vascular Surgery, Methodist Dallas Medical Center. "This product offers the same excellent performance I have come to expect from the Sterling family of balloon catheters."
"The Sterling SL Balloon Catheter reflects Boston Scientific's commitment to providing physicians the most complete set of high-performance peripheral intervention devices," said Joe Fitzgerald, Senior Vice President and President of Boston Scientific's Endovascular Unit. "The Sterling family is the world's best selling line of low-profile peripheral angioplasty balloon catheters, and this expanded offering will help reinforce its reputation as a preferred solution for physicians treating peripheral vascular lesions."
Analysis shows gender and racial disparities in pulmonary embolism treatment